These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6259732)

  • 1. Morphiceptin (NH4-tyr-pro-phe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors.
    Chang KJ; Lillian A; Hazum E; Cuatrecasas P; Chang JK
    Science; 1981 Apr; 212(4490):75-7. PubMed ID: 6259732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
    Chang KJ; Wei ET; Killian A; Chang JK
    J Pharmacol Exp Ther; 1983 Nov; 227(2):403-8. PubMed ID: 6313901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanyl nucleotide interactions with opiate receptors in guinea pig brain and ileum.
    Zukin RS; Gintzler AR
    Brain Res; 1980 Mar; 186(2):486-91. PubMed ID: 6244063
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid activity of pro-enkephalin-derived peptides in mouse vas deferens and guinea pig ileum.
    Sánchez-Blázquez P; Garzón J
    Neurosci Lett; 1985 Nov; 61(3):267-71. PubMed ID: 3001596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of enkephalin analogs at opiate and enkephalin receptors: correlation with analgesia.
    Audigier Y; Mazarguil H; Gout R; Cros J
    Eur J Pharmacol; 1980 Apr; 63(1):35-46. PubMed ID: 6247160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of morphine-epoxide with multiple opiate receptors.
    Konno F; Shibata R; Takayanagi I; Hirobe M
    J Pharmacobiodyn; 1984 Apr; 7(4):221-6. PubMed ID: 6088751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco mosaic virus-enkephalin conjugates: potentiation of opioid activity.
    Kriwaczek VM; Schwyzer R; Gillan MG; Paterson SJ; Kosterlitz HW
    Peptides; 1981; 2(1):89-92. PubMed ID: 6264412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific protection of the binding sites of D-Ala2-D-Leu5-enkephalin (delta-receptors) and dihydromorphine (mu-receptors).
    Robson LE; Kosterlitz HW
    Proc R Soc Lond B Biol Sci; 1979 Aug; 205(1160):425-32. PubMed ID: 41257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of the preferential involvement of mu receptors in analgesia using enkephalins highly selective for peripheral mu or delta receptors.
    Gacel G; Fournié-Zaluski MC; Fellion E; Roques BP
    J Med Chem; 1981 Oct; 24(10):1119-24. PubMed ID: 6276540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphiceptin ( beta-casomorphin (1-4) amide): a peptide opioid antagonist in the field stimulated rat vas deferens.
    Day AR; Freer RJ; Liao CS
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):543-6. PubMed ID: 6275472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topochemical analysis of morphiceptin and dermorphin bioactivities.
    Yamazaki T; Ro S; Goodman M
    Biochem Biophys Res Commun; 1991 Dec; 181(2):664-70. PubMed ID: 1661586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey.
    Hutchinson M; Kosterlitz HW; Leslie FM; Waterfield AA
    Br J Pharmacol; 1975 Dec; 55(4):541-6. PubMed ID: 2359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
    Hayes AG; Sheehan MJ; Tyers MB
    Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
    Cohen ML; Shuman RT; Osborne JJ; Gesellchen PD
    J Pharmacol Exp Ther; 1986 Sep; 238(3):769-72. PubMed ID: 2875170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of cyclic beta-casomorphin-5 analogues.
    Schmidt R; Neubert K; Barth A; Liebmann C; Schnittler M; Chung NN; Schiller PW
    Peptides; 1991; 12(6):1175-80. PubMed ID: 1667685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of the epsilon-opiate receptor.
    Schulz R; Wüster M; Herz A
    J Pharmacol Exp Ther; 1981 Mar; 216(3):604-6. PubMed ID: 6259326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.